HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hwan-Mook Kim Selected Research

Albumins

1/2006Delayed occurrence of H-ras12V-induced hepatocellular carcinoma with long-term treatment with cinnamaldehydes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hwan-Mook Kim Research Topics

Disease

24Neoplasms (Cancer)
09/2015 - 03/2002
3Colorectal Neoplasms (Colorectal Cancer)
09/2015 - 09/2008
3Colonic Neoplasms (Colon Cancer)
04/2015 - 02/2010
3Carcinoma (Carcinomatosis)
12/2013 - 02/2004
2Leukemia
03/2019 - 02/2010
2Carcinogenesis
06/2011 - 10/2010
2Hypoxia (Hypoxemia)
10/2010 - 03/2010
1Breast Neoplasms (Breast Cancer)
07/2014
1Neoplastic Cell Transformation
07/2014
1Prostatic Neoplasms (Prostate Cancer)
01/2014
1Glioblastoma (Glioblastoma Multiforme)
02/2012
1Brain Neoplasms (Brain Tumor)
02/2012
1Urinary Bladder Neoplasms (Bladder Cancer)
06/2011
1Body Weight (Weight, Body)
06/2011
1Dyslexia (Alexia)
01/2011
1Neoplasm Metastasis (Metastasis)
03/2010
1Inflammation (Inflammations)
09/2008
1Stomach Neoplasms (Stomach Cancer)
09/2008
1Hepatocellular Carcinoma (Hepatoma)
01/2006
1Asthma (Bronchial Asthma)
01/2006
1Experimental Melanoma
02/2005
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2004
1Adenocarcinoma
05/2004
1Lung Neoplasms (Lung Cancer)
01/2004
1Melanoma (Melanoma, Malignant)
01/2003

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
03/2019 - 02/2004
6Doxorubicin (Adriamycin)FDA LinkGeneric
08/2011 - 01/2003
3DNA (Deoxyribonucleic Acid)IBA
04/2012 - 03/2002
3TransferasesIBA
04/2006 - 02/2004
2Histone Deacetylase InhibitorsIBA
07/2014 - 09/2008
2anthraceneIBA
05/2010 - 08/2008
22'-benzoyloxycinnamaldehydeIBA
01/2006 - 02/2004
1Lysine (L-Lysine)FDA Link
03/2019
1Histones (Histone)IBA
03/2019
1MethyltransferasesIBA
03/2019
1Irinotecan (Camptosar)FDA LinkGeneric
09/2015
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2015
1Neutralizing AntibodiesIBA
09/2015
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
04/2015
1TNF-Related Apoptosis-Inducing LigandIBA
04/2015
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2015
1CG100649IBA
04/2015
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
04/2015
1Epidermal Growth Factor (EGF)IBA
07/2014
14- hexadecanoyl- 1,1- dimethylpiperazin- 1- iumIBA
01/2014
1BromidesIBA
12/2013
1GinsenosidesIBA
07/2013
1Tuberculin (PPD)IBA
07/2013
1protopanaxadiolIBA
07/2013
1Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
07/2013
1LipidsIBA
07/2013
1hydrogen sulfite (bisulfite)IBA
04/2012
1Biomarkers (Surrogate Marker)IBA
04/2012
1RolipramIBA
02/2012
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
02/2012
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
02/2012
1Phosphodiesterase InhibitorsIBA
02/2012
1N- (2- chloroacetyl)- 6- (2- oxo- 4- phenylimidazolidin- 1- ylsulfonyl)- 3,4- dihydroquinoline- 1(2H)- carboxamideIBA
08/2011
1N- cyclohexyl- 6- (2- oxo- 4- phenylimidazolidin- 1- ylsulfonyl)- 3,4- dihydroquinoline- 1(2H)- carboxamideIBA
08/2011
1Antineoplastic Agents (Antineoplastics)IBA
06/2011
1CarcinogensIBA
06/2011
1ChromatinIBA
06/2011
1Niacinamide (Nicotinamide)FDA LinkGeneric
06/2011
1NitrosaminesIBA
06/2011
1Therapeutic UsesIBA
06/2011
1RNA Precursors (Precursor, mRNA)IBA
01/2011
1titanium dioxide (Titania)FDA Link
01/2011
1Cell Cycle ProteinsIBA
10/2010
1Diethylnitrosamine (N-Nitrosodiethylamine)IBA
10/2010
1Cholecalciferol (Vitamin D3)FDA Link
10/2010
1Hypoxia-Inducible Factor 1IBA
03/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2010
1Ether (Diethyl Ether)IBA
02/2010
1honokiolIBA
09/2008
1LignansIBA
09/2008
1obovatolIBA
09/2008
1magnololIBA
09/2008
1DecitabineFDA Link
09/2008
1trichostatin A (A 300)IBA
09/2008
1Leucine (L-Leucine)FDA Link
09/2008
1Hydroxylamine (Hydroxylamine Hydrochloride)IBA
10/2007
1Dihydrotachysterol (AT 10)IBA
04/2006
1AlbuminsIBA
01/2006
1cinnamaldehyde (cinnamic aldehyde)FDA Link
01/2006
1Terminator Codon (Termination Codon)IBA
01/2006
1Messenger RNA (mRNA)IBA
01/2006
1B-Cell Activating FactorIBA
01/2006
1Immunoglobulin E (IgE)IBA
01/2006
1Caspase 3 (Caspase-3)IBA
11/2005
1methyllucidoneIBA
11/2005
1Polysaccharides (Glycans)IBA
02/2005
1GlucansIBA
02/2005
1indolineIBA
05/2004
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2004

Therapy/Procedure

2Therapeutics
10/2010 - 02/2004
1Drug Therapy (Chemotherapy)
07/2013
1Immunomodulation
01/2011